400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Metabolic Enzyme / SGK / GSK 650394
CAS No.: 890842-28-1
Synonyms: GSK650394
GSK650394 inhibits the activities of SGK1 and SGK2 with IC50 of 62 nM and 103 nM, respectively.
生物活性
实验方案
技术信息
CAS号 | 890842-28-1 | 储存条件 |
|
|||||||
分子式 | C25H22N2O2 | 运输 | 蓝冰 | |||||||
分子量 | 382.45 | 别名 | GSK650394 | |||||||
溶解度 |
|
动物实验配方 |
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
human 5637 cell | - | Growth inhibition assay | - | Inhibition of human 5637 cell growth in a cell viability assay, IC50=3.20669 μM | SANGER |
human 786-0 cell | - | Growth inhibition assay | - | Inhibition of human 786-0 cell growth in a cell viability assay, IC50=2.94825 μM | SANGER |
human A375 cell | - | Growth inhibition assay | - | Inhibition of human A375 cell growth in a cell viability assay, IC50=5.25492 μM | SANGER |
human A388 cell | - | Growth inhibition assay | - | Inhibition of human A388 cell growth in a cell viability assay, IC50=7.59965 μM | SANGER |
human A427 cell | - | Growth inhibition assay | - | Inhibition of human A427 cell growth in a cell viability assay, IC50=1.87611 μM | SANGER |
human A431 cell | - | Growth inhibition assay | - | Inhibition of human A431 cell growth in a cell viability assay, IC50=1.85902 μM | SANGER |
human BC-1 cell | - | Growth inhibition assay | - | Inhibition of human BC-1 cell growth in a cell viability assay, IC50=2.51651 μM | SANGER |
human BC-3 cell | - | Growth inhibition assay | - | Inhibition of human BC-3 cell growth in a cell viability assay, IC50=1.87094 μM | SANGER |
human BFTC-905 cell | - | Growth inhibition assay | - | Inhibition of human BFTC-905 cell growth in a cell viability assay, IC50=0.78455 μM | SANGER |
human CAL-12T cell | - | Growth inhibition assay | - | Inhibition of human CAL-12T cell growth in a cell viability assay, IC50=2.71158 μM | SANGER |
human CAL-27 cell | - | Growth inhibition assay | - | Inhibition of human CAL-27 cell growth in a cell viability assay, IC50=5.33221 μM | SANGER |
human CAL-51 cell | - | Growth inhibition assay | - | Inhibition of human CAL-51 cell growth in a cell viability assay, IC50=5.35583 μM | SANGER |
human CHL-1 cell | - | Growth inhibition assay | - | Inhibition of human CHL-1 cell growth in a cell viability assay, IC50=3.49665 μM | SANGER |
human CMK cell | - | Growth inhibition assay | - | Inhibition of human CMK cell growth in a cell viability assay, IC50=8.25377 μM | SANGER |
human Daoy cell | - | Growth inhibition assay | - | Inhibition of human Daoy cell growth in a cell viability assay, IC50=0.51532 μM | SANGER |
human DU-145 cell | - | Growth inhibition assay | - | Inhibition of human DU-145 cell growth in a cell viability assay, IC50=20.4955 μM | SANGER |
human ES4 cell | - | Growth inhibition assay | - | Inhibition of human ES4 cell growth in a cell viability assay, IC50=4.06069 μM | SANGER |
human EW-13 cell | - | Growth inhibition assay | - | Inhibition of human EW-13 cell growth in a cell viability assay, IC50=3.01558 μM | SANGER |
human G-361 cell | - | Growth inhibition assay | - | Inhibition of human G-361 cell growth in a cell viability assay, IC50=3.71745 μM | SANGER |
human GDM-1 cell | - | Growth inhibition assay | - | Inhibition of human GDM-1 cell growth in a cell viability assay, IC50=0.87937 μM | SANGER |
human H4 cell | - | Growth inhibition assay | - | Inhibition of human H4 cell growth in a cell viability assay, IC50=21.4244 μM | SANGER |
human HCT-15 cell | - | Growth inhibition assay | - | Inhibition of human HCT-15 cell growth in a cell viability assay, IC50=3.62842 μM | SANGER |
human HEL cell | - | Growth inhibition assay | - | Inhibition of human HEL cell growth in a cell viability assay, IC50=10.68 μM | SANGER |
human HGC-27 cell | - | Growth inhibition assay | - | Inhibition of human HGC-27 cell growth in a cell viability assay, IC50=1.30821 μM | SANGER |
human HLE cell | - | Growth inhibition assay | - | Inhibition of human HLE cell growth in a cell viability assay, IC50=1.42683 μM | SANGER |
human HOS cell | - | Growth inhibition assay | - | Inhibition of human HOS cell growth in a cell viability assay, IC50=1.97312 μM | SANGER |
human HT-1080 cell | - | Growth inhibition assay | - | Inhibition of human HT-1080 cell growth in a cell viability assay, IC50=5.49347 μM | SANGER |
human HT-29 cell | - | Growth inhibition assay | - | Inhibition of human HT-29 cell growth in a cell viability assay, IC50=7.26843 μM | SANGER |
human HuH-7 cell | - | Growth inhibition assay | - | Inhibition of human HuH-7 cell growth in a cell viability assay, IC50=18.2783 μM | SANGER |
human HuP-T4 cell | - | Growth inhibition assay | - | Inhibition of human HuP-T4 cell growth in a cell viability assay, IC50=8.50234 μM | SANGER |
human HUTU-80 cell | - | Growth inhibition assay | - | Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50=1.30172 μM | SANGER |
human IGR-1 cell | - | Growth inhibition assay | - | Inhibition of human IGR-1 cell growth in a cell viability assay, IC50=4.233 μM | SANGER |
human KM12 cell | - | Growth inhibition assay | - | Inhibition of human KM12 cell growth in a cell viability assay, IC50=0.85069 μM | SANGER |
human KU812 cell | - | Growth inhibition assay | - | Inhibition of human KU812 cell growth in a cell viability assay, IC50=2.1871 μM | SANGER |
human LCLC-97TM1 cell | - | Growth inhibition assay | - | Inhibition of human LCLC-97TM1 cell growth in a cell viability assay, IC50=1.36768 μM | SANGER |
human LoVo cell | - | Growth inhibition assay | - | Inhibition of human LoVo cell growth in a cell viability assay, IC50=9.91292 μM | SANGER |
human LXF-289 cell | - | Growth inhibition assay | - | Inhibition of human LXF-289 cell growth in a cell viability assay, IC50=1.40152 μM | SANGER |
human M-1 cells | - | Function assay | - | Inhibition of SGK1-mediated epithelial sodium channel activity in human M-1 cells assessed as short circuit current by whole cell electrophysiological transepithelial experiment, IC50=0.58 μM | 19497745 |
human MC116 cell | - | Growth inhibition assay | - | Inhibition of human MC116 cell growth in a cell viability assay, IC50=21.2676 μM | SANGER |
human MCF7 cell | - | Growth inhibition assay | - | Inhibition of human MCF7 cell growth in a cell viability assay, IC50=1.8178 μM | SANGER |
human MFH-ino cell | - | Growth inhibition assay | - | Inhibition of human MFH-ino cell growth in a cell viability assay, IC50=1.98658 μM | SANGER |
human MKN1 cell | - | Growth inhibition assay | - | Inhibition of human MKN1 cell growth in a cell viability assay, IC50=9.18565 μM | SANGER |
human MOLT-16 cell | - | Growth inhibition assay | - | Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50=3.51555 μM | SANGER |
human MONO-MAC-6 cell | - | Growth inhibition assay | - | Inhibition of human MONO-MAC-6 cell growth in a cell viability assay, IC50=1.18097 μM | SANGER |
human MV-4-11 cell | - | Growth inhibition assay | - | Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50=0.1649 μM | SANGER |
human NCI-H1299 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H1299 cell growth in a cell viability assay, IC50=5.98557 μM | SANGER |
human NCI-H2122 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H2122 cell growth in a cell viability assay, IC50=3.333 μM | SANGER |
human NCI-H2342 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50=2.19053 μM | SANGER |
human NCI-H460 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H460 cell growth in a cell viability assay, IC50=3.4041 μM | SANGER |
human NKM-1 cell | - | Growth inhibition assay | - | Inhibition of human NKM-1 cell growth in a cell viability assay, IC50=2.76731 μM | SANGER |
human OCUB-M cell | - | Growth inhibition assay | - | Inhibition of human OCUB-M cell growth in a cell viability assay, IC50=2.78861 μM | SANGER |
human PA-1 cell | - | Growth inhibition assay | - | Inhibition of human PA-1 cell growth in a cell viability assay, IC50=3.33083 μM | SANGER |
human RKO cell | - | Growth inhibition assay | - | Inhibition of human RKO cell growth in a cell viability assay, IC50=1.57869 μM | SANGER |
human RT-112 cell | - | Growth inhibition assay | - | Inhibition of human RT-112 cell growth in a cell viability assay, IC50=1.02782 μM | SANGER |
human SF126 cell | - | Growth inhibition assay | - | Inhibition of human SF126 cell growth in a cell viability assay, IC50=8.80208 μM | SANGER |
human SK-LMS-1 cell | - | Growth inhibition assay | - | Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50=5.38255 μM | SANGER |
human SK-LU-1 cell | - | Growth inhibition assay | - | Inhibition of human SK-LU-1 cell growth in a cell viability assay, IC50=3.97014 μM | SANGER |
human SK-MEL-3 cell | - | Growth inhibition assay | - | Inhibition of human SK-MEL-3 cell growth in a cell viability assay, IC50=30.0228 μM | SANGER |
human SK-MEL-30 cell | - | Growth inhibition assay | - | Inhibition of human SK-MEL-30 cell growth in a cell viability assay, IC50=7.97215 μM | SANGER |
human SNG-M cell | - | Growth inhibition assay | - | Inhibition of human SNG-M cell growth in a cell viability assay, IC50=1.79853 μM | SANGER |
human SW1710 cell | - | Growth inhibition assay | - | Inhibition of human SW1710 cell growth in a cell viability assay, IC50=2.70082 μM | SANGER |
human SW620 cell | - | Growth inhibition assay | - | Inhibition of human SW620 cell growth in a cell viability assay, IC50=1.92816 μM | SANGER |
human SW872 cell | - | Growth inhibition assay | - | Inhibition of human SW872 cell growth in a cell viability assay, IC50=13.6896 μM | SANGER |
human SW954 cell | - | Growth inhibition assay | - | Inhibition of human SW954 cell growth in a cell viability assay, IC50=4.46124 μM | SANGER |
human SW982 cell | - | Growth inhibition assay | - | Inhibition of human SW982 cell growth in a cell viability assay, IC50=13.7916 μM | SANGER |
human T84 cell | - | Growth inhibition assay | - | Inhibition of human T84 cell growth in a cell viability assay, IC50=2.60446 μM | SANGER |
human TE-12 cell | - | Growth inhibition assay | - | Inhibition of human TE-12 cell growth in a cell viability assay, IC50=1.99128 μM | SANGER |
human TE-15 cell | - | Growth inhibition assay | - | Inhibition of human TE-15 cell growth in a cell viability assay, IC50=2.59181 μM | SANGER |
human TE-8 cell | - | Growth inhibition assay | - | Inhibition of human TE-8 cell growth in a cell viability assay, IC50=4.11582 μM | SANGER |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网